- Benchmark initiated coverage on Cantel Medical Corp. CMN with a Buy rating. The price target for Cantel Medical is set to $83. Cantel Medical shares rose 0.35 percent to close at $72.03 on Friday.
- Analysts at Janney Capital initiated coverage on Recro Pharma Inc REPH with a Buy rating. Recro Pharma shares fell 0.11 percent to close at $9.15 on Friday.
- Analysts at Morgan Stanley initiated coverage of At Home Group Inc. HOME with an Equal-Weight rating. The price target for First At Home Group is set to $17. At Home Group shares closed at $16.08 on Friday.
- Analysts at UBS initiated coverage on First Hawaiian Inc FHB with a Neutral rating. The price target for First Hawaiian is set to $28. First Hawaiian shares slipped 0.67 percent to close at $26.57 on Friday.
- Analysts at Evercore ISI Group initiated coverage on Theravance Biopharma Inc TBPH with an Buy rating. The price target for Theravance Biopharma is set to $41. Theravance Biopharma shares rose 0.04 percent to close at $28.18 on Friday.
- Axiom Capital initiated coverage of Netflix, Inc. NFLX with a Sell rating. The price target for Netflix is set to $80. Netflix shares fell 0.95 percent to $96.65 in pre-market trading.
- Goldman Sachs initiated coverage on At Home Group Inc. HOME with a Neutral rating. The price target for First At Home Group is set to $17. At Home Group shares closed at $16.08 on Friday.
- Analysts at KLR Group initiated coverage on Encana Corp (USA) ECA with a Hold rating. Encana shares declined 0.10 percent to $9.91 in pre-market trading.
- Analysts at Credit Suisse initiated coverage of First Hawaiian Inc FHB with an Outperform rating. The price target for First Hawaiian is set to $29. First Hawaiian shares slipped 0.67 percent to close at $26.57 on Friday.
- Analysts at Craig-Hallum initiated coverage on Invuity, Inc. IVTY with a Buy rating. The price target for Invuity is set to $25. Invuity shares fell 0.62 percent to close at $12.74 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in